Clinical trial Recruiting at 1 site Observational Ages 18 and up

Periodontal Health in Rare Kidney Conditions and Controls

Official title: Periodontal Inflammation in Rare Renal Disorders - A Cross-Sectional Controlled Observational Study Assessing the Burden and Phenotypes of Periodontal Disease

Run by Institutul Clinic Fundeni · NCT07575347 · Data updated 2026-11-12

This study tests how common periodontitis is in people with rare kidney disorders and compares it to CKD patients and people without kidney disease.

More Chronic Kidney Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorInstitutul Clinic Fundeni
Academic / other
Locations1 site (Bucharest)
StatusRecruiting
StartedMay 4, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJune 26, 2026
Trial IDNCT07575347 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with confirmed Alport syndrome, Fabry disease, tuberous sclerosis complex, SLE with renal involvement, CKD of non-rare etiology, or non-CKD controls, and at least 10 natural teeth.

Probably not a fit

Recipients with well-controlled periodontal health and without kidney disease may see limited direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional, case-control study will compare the prevalence and severity of periodontal disease among people with Alport syndrome, Fabry disease, tuberous sclerosis complex, SLE with kidney involvement, CKD of non-rare etiology, and non-CKD controls. Participants will have a single visit with a full-mouth periodontal exam, a structured questionnaire, and extraction of relevant medical data. Outcomes include prevalence of periodontitis, disease severity, gingivitis, xerostomia, and potential associations with kidney function and immunosuppressive exposure. Analyses will use descriptive statistics, group comparisons, and multivariable models adjusting for confounders.

Why it matters

Potential benefit: If successful, findings could clarify risk patterns and inform dental monitoring strategies for people with rare kidney diseases and CKD.

How similar studies have gone: Previous research links periodontal disease with CKD, but data in rare kidney disorders are limited, making this study relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Ability to provide written informed consent
* At least 10 natural teeth present
* Belonging to one of the predefined study groups:

  1. Alport syndrome (genetically or clinically confirmed)
  2. Fabry disease (enzymatically or genetically confirmed)
  3. Tuberous sclerosis complex (according to established clinical or genetic criteria)
  4. Systemic lupus erythematosus defined according to the 2019 EULAR/ACR or SLICC 2012 classification criteria, with renal involvement defined by at least one of the following: \[1\] Biopsy-proven lupus nephritis, \[2\] Persistent proteinuria (\>0.5 g/day or equivalent), \[3\] Active urinary sediment (hematuria and/or cellular casts) consistent with lupus nephritis
  5. Chronic kidney disease (CKD) of non-rare etiology: defined according to KDIGO criteria (eGFR \<60 ml/min/1.73 m² and/or markers of kidney damage)
  6. Individuals without CKD, recruited from clinical or dental care settings as non-CKD controls

Exclusion Criteria:

* Periodontal treatment within the last 6 months
* Antibiotic therapy within the last 4 weeks
* Pregnancy
* Conditions precluding periodontal examination
* Inability to comply with study procedures

Where it's running

  • Fundeni Clinical Institute
    Bucharest, Romania
    Recruiting

Study contacts

  • Principal investigator: Bahtiar Ismail, MD, PhD — Emergency University Hospital Bucharest
  • Study coordinator: Stefan N Lujinschi, MD, PhD candidate
  • Email: stefanlujinschi@gmail.com
  • Phone: +40728102643

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.